Scientists at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage caused ...

Nine million people globally still lack access to life-saving HIV treatment, even as new infections continue to rise in ...

An international clinical trial led by researchers including Professor Chloe Orkin of Queen Mary University of London has ...

– Latest Data from the PURPOSE Program Further Demonstrates the Safety and Efficacy Profile of Twice-Yearly Lenacapavir for HIV Prevention – “Striving for continuous progress in HIV means delivering ...

Among healthcare providers, 89% (n=16/18) reported a positive overall opinion of administering CAB LA for PrEP in their practice. Prescribers cited benefits of regular injection visits, including ...

Once-daily, single-tablet regimens have transformed care for persons living with human immunodeficiency virus type 1 (HIV-1); ...

Over the past 30 years international investment has enabled millions of people to obtain a diagnosis of HIV and receive ...

A new single-pill HIV treatment has proved as effective as regimens of up to 11 tablets a day in suppressing the virus in hard-to-treat patients. It’s “a potential breakthrough for a growing cohort of ...

Metro Atlanta continues to face 'unacceptably high' rates of new HIV infections, researchers at Emory School of Medicine said.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Example antibody-drug conjugate A recent experimental treatment may offer a new method to ...

For more than four decades, HIV has been one of the world's most discussed infections. Yet, surprisingly, it remains one of ...